Oct 6, 2026 (Tuesday) - Elevador Lacerda Auditorium
Chair: Antonio Carlos de Souza (DF)Moderator: Claudio Nhuch (RS)Discussant: Flavia Lins de Souza Fonseca (PE)Discussant: Nostradamus Coelho (RJ)Discussant: Adriano de Araújo Melo (BA)
| 08:30 - 08:38 |
Doppler ultrasound: diagnosis, planning or ritual? - understanding venous haemodynamics
Robson Barbosa de Miranda (SP)
|
| 08:38 - 08:46 |
Venous mapping in C1/C2: technological dependence or real clinical gain?
Renata Lúcia Barreto de Andrade Lima Netto (PE)
|
| 08:46 - 08:54 |
Perforators: physiological interpretation and impact on treatment
Felipe Puricelli Faccini (RS)
|
| 08:54 - 09:02 |
Diseased saphenous vein: treat the anatomy, the ultrasound or the patient?
Felipe Coelho Neto (PR)
|
| 09:02 - 09:10 |
Related paper: Simplified photoshop-based grayscale analysis of residual thrombus for predicting post-thrombotic syndrome and recurrence
Arlindo Nascimento de Lemos Júnior (SP)
|
| 09:10 - 09:30 |
Discussion
|
Chair: Adriana Vasconcelos (RJ)Moderator: Adriana Ferraz (PE)Discussant: Angela Claudia Paixão Soares de Magalhães (AC)Discussant: Silvio Alves da Silva (TO)Discussant: Carlos Seme Nejm Júnior (PR)
| 09:30 - 09:38 |
Pelvic pain: what is essential for the diagnosis of chronic pelvic pain?
Clovis Bordini Racy Filho (RJ)
|
| 09:38 - 09:46 |
Compression syndromes: how to assess haemodynamics and quantify stenosis
Wanderbilt Duarte de Barros Neto (SP)
|
| 09:46 - 09:54 |
Pelvic venous thrombosis: a hidden and risky source?
Isabela Rodrigies Tavares (SP)
|
| 09:54 - 10:02 |
Rethrombosis: the greatest challenge in Doppler ultrasound assessment?
Marcelo Melzer Teruchkin (RS)
|
| 10:02 - 10:10 |
Challenging clinical case
Emmanuelle Tenorio Albuquerque Godoi (PE)
|
| 10:10 - 10:30 |
Discussion
|
10:30 - 11:00
COFFEE BREAK
Chair: Bruno de Lima Naves (MG)Moderator: Gustavo Braga Murta (MG)Discussant: Fernando Três Silveira (PR)Discussant: Arlindo Nascimento de Lemos Junior (SP)Discussant: Fernanda de Souza Marchezini (BA)
| 11:00 - 11:08 |
What is the landscape of surgical treatment of varicose veins in Brazil?
Paulo Antonaccio (SP)
|
| 11:08 - 11:16 |
Ultrasound-guided foam in the saphenous vein: established effectiveness or still under debate?
Mario Sica (FRA)
|
| 11:16 - 11:24 |
Are there limits to dense foam sclerotherapy: what are they?
Francisco Reis Bastos (MG)
|
| 11:24 - 11:32 |
Conventional surgery vs. endovenous ablation: is there a winner?
Marcelo Halfen Grill (SP)
|
| 11:32 - 11:40 |
Challenging edited case - Venclose
Surgeon: Lina Vargas (USA) - Presenter: Arthur Curtarelli (SP)
|
| 11:40 - 12:00 |
Discussion
|
Speakers: Dr. Fabricio Rodrigues Santiago and Dr. Rodrigo Rial
Chair: Maria Elisabeth Rennó de Castro Santos (MG)Moderator: Suzanna Maria Viana Sanches (BA)Discussant: Ricardo Augusto de Almeida Correia (AL)Discussant: Andréa Corleto Hoelzl (PR)Discussant: Patricia Jorge Bittencourt (PR)
| 13:30 - 13:38 |
Superficial venous thrombosis: when is it really a concern?
Alcides José Araujo Ribeiro (DF)
|
| 13:38 - 13:46 |
Choosing the anticoagulant in VTE: how to individualise treatment?
Adilson Ferraz Paschôa (SP)
|
| 13:46 - 13:54 |
Extended anticoagulant therapy
Marcos Arêas Marques (RJ)
|
| 13:54 - 14:02 |
Complex venous thrombosis: what defines efficient thrombus removal?
Bruna De Fina (SP)
|
| 14:02 - 14:10 |
Hormonal implants and VTE: weighing risk and benefit
Eduardo Ramacciotti (SP)
|
| 14:10 - 14:30 |
Discussion
|
Chair: Sérgio Meirelles (RJ)Moderator: Marcelo Melzer Teruchkin (RS)Discussant: Alcides José Araujo Ribeiro (DF)Discussant: Fabricio Rodrigues Santiago (GO)Discussant: Harue Santiago Kumakura (SP)
| 14:30 - 14:38 |
Bleeding risk: how to assess it and define the best management?
Paulo Martins Toscano (RJ)
|
| 14:38 - 14:46 |
Which tests are essential before starting anticoagulation for VTE?
Adilson Ferraz Paschôa (SP)
|
| 14:46 - 14:54 |
Can anticoagulation be resumed after a bleeding episode, and when?
Marcone Lima Sobreira (SP)
|
| 14:54 - 15:02 |
Perioperative anticoagulation: how to manage it?
Ricardo Augusto de Almeida Correia (AL)
|
| 15:02 - 15:10 |
New anticoagulants: what is the outlook for the future of anticoagulation?
Eduardo Ramacciotti (SP)
|
| 15:10 - 15:30 |
Discussion
|
15:30 - 16:00
COFFEE BREAK
Chair: Pedro Pablo Komlós (RS)Moderator: Felipe Coelho Neto (PR)Discussant: Leonardo Pires de Sá Nobrega (DF)Discussant: Maria Clara Pereira Sanjuan (BA)Discussant: Valéria Aguiar (SP)
| 16:00 - 16:08 |
Hyperpigmentation: how to manage it before and after the procedure?
Brenno Augusto Seabra de Mello Netto (ES)
|
| 16:08 - 16:16 |
Matting: who is at greater risk?
Elias Arcenio Neto (PR)
|
| 16:16 - 16:24 |
Thrombosis after varicose vein procedures: how to diagnose and manage treatment?
Maysa Heineck Cury (SP)
|
| 16:24 - 16:32 |
Liquid sclerotherapy: is the complication avoidable, and how?
Anelise Rodrigues Bezerra dos Santos (MT)
|
| 16:32 - 16:40 |
Laser treatment of post-inflammatory hyperpigmentation after sclerotherapy
Fernando Três Silveira (ES)
|
| 16:40 - 17:00 |
Discussion
|
Oct 7, 2026 (Wednesday) - Elevador Lacerda Auditorium
Chair: Francisco Reis Bastos (MG)Moderator: José Ben-Hur Ferraz Parente (SP)Discussant: Glenda Myriam de Souza Rocha (RN)Discussant: Eduardo Toledo de Aguiar (SP)Discussant: Marcelo Ruettimann Liberato de Moura (BA)
| 08:30 - 08:32 |
Session opening
|
| 08:32 - 08:40 |
Should I discard my 1470 nm laser and buy a 1940 nm laser? Is the new wavelength really a game changer?
Nicolas Neaume (FRA)
|
| 08:40 - 08:48 |
Why and in which patients to reduce varicose vein diameter before foam sclerotherapy
Gilles Gachet (FRA)
|
| 08:48 - 08:56 |
Non-thermal HIFU: a promising device for the treatment of varicose veins
Olivier Pichot (FRA)
|
| 08:56 - 09:04 |
Enhancing ultrasound-guided foam sclerotherapy of the saphenous veins with 3D ultrasound imaging
Mario Sica (FRA)
|
| 09:04 - 09:12 |
SALFOAM 3%: foam sclerotherapy through a different perspective
Lidiane Rocha (SP)
|
| 09:12 - 09:30 |
Discussion
|
Chair: Fausto Miranda Júnior (SP)Moderator: Maurício de Amorim Aquino (BA)Discussant: Ana Clarice Bacelar (BA)Discussant: Fernando de Assis Figueiredo Júnior (MG)Discussant: Patricia Jorge Bittencourt (PR)
| 09:30 - 09:38 |
Post-thrombotic obstructive syndromes: when to study the abdominopelvic axis?
Nathalia Cardoso Oliveira (MA)
|
| 09:38 - 09:46 |
What does deep venous reflux really mean for the treatment of varicose veins?
Robson Barbosa de Miranda (SP)
|
| 09:46 - 09:54 |
Post-thrombotic follow-up with duplex ultrasound: what do the guidelines say?
Silvio Alves da Silva (TO)
|
| 09:54 - 10:02 |
What does the new evidence show for endovascular treatment and how should it be interpreted?
Giuliano Giova Volpiani (SP)
|
| 10:02 - 10:10 |
Complex case: therapeutic challenge - non-thrombotic Cockett syndrome
Patrick Bastos Metzger (BA) - Miguel Monteiro Tannus (SP) - Gabriel Carvalho (BA) and Marcus V.B. Alves (BA)
|
| 10:10 - 10:30 |
Discussion
|
10:30 - 11:00
COFFEE BREAK
Chair: Walter Campos Júnior (SP)Moderator: Regis Fernando Angnes (RS)Discussant: Fábio José Bonafé Sotelo (SP)Discussant: Elizabeth Moreno Ayres da Costa (PE)Discussant: Ivanésio Merlo (RJ)
| 11:00 - 11:08 |
Advances in the consensus on CVD and diabetes mellitus
Oscar Bottini (ARG)
|
| 11:08 - 11:16 |
Drug treatment of CVD: what does current evidence say?
Juliana Puggina (SP)
|
| 11:16 - 11:24 |
Does treating perforator disease change the course of the disease?
Marcelo Eckert Zanoni(SC)
|
| 11:24 - 11:32 |
Non-saphenous varicose veins: interventions beyond the superficial venous system
Alexandre Shiomi (PR)
|
| 11:32 - 11:40 |
Live case INN-FIBER VENOLASER CROMATIC: treatment of perforator veins with endolaser
Surgeon: Alexandre Antonaccio (SP) and Facilitator: Paulo Antonaccio (SP)
|
| 11:40 - 12:00 |
Discussion
|
Keynote Speaker: Gutenberg do Amaral Gurgel (RN)Moderator: Dejean Sampaio Amorim Filho (BA)
Speakers: Brenno Augusto Seabra de Mello Netto (ES), Bernardo Cunha Senra Barros (RJ) and Elias Arcenio Neto (PR)
Chair: Winston Bonetti Yoshida(SP)Moderator: Marcelo Calil Burihan (SP)Discussant: Taís Mori Sério (SP)Discussant: Isabelle Silva Queiroz Oliveira (BA)Discussant: Thiago de Souza Carvalho (MG)
| 13:30 - 13:38 |
When is pharmacological prophylaxis essential?
Luiz Eduardo Almeida e Silva (DF)
|
| 13:38 - 13:46 |
Vena cava filters: current indications and limitations in practice
Giuliano de Almeida Sandri (ES)
|
| 13:46 - 13:54 |
Choosing the anticoagulant: deciding between options in challenging cases
Suzanna Maria Viana Sanches (BA)
|
| 13:54 - 14:02 |
VTE prophylaxis: how to balance risk and benefit in practice
Marcone Lima Sobreira (SP)
|
| 14:02 - 14:10 |
Challenging clinical case: iliocaval mechanical thrombectomy
Patrick Bastos Metzger (BA)
|
| 14:10 - 14:30 |
Discussion
|
Chair: Getulio Ferreira Câmara Nunes (PB)Moderator: Tiago Rodrigues Cavalcante (MA)Discussant: Thales Borges Marques (MG)Discussant: Victor Hugo Guerreiro Américo Gomes (PA)Discussant: Solange Seguro Meyge Evangelista (MG)
| 14:30 - 14:38 |
New foam delivery methods for saphenous and tributary veins: do they change outcomes?
Giovani Alonghi (ITA)
|
| 14:38 - 14:46 |
When and how to combine other venous treatment techniques with ultrasound-guided foam?
Gianluigi Rosi (ITA)
|
| 14:46 - 14:54 |
Foam sclerotherapy in pelvic venous disease: how to achieve the best results?
Francisco Reis Bastos (MG)
|
| 14:54 - 15:02 |
Challenging clinical case: how to achieve effective results with foam
Marcelo Ruettimann Liberato de Moura (BA)
|
| 15:02 - 15:30 |
Discussion
|
Chair: Walter Campos Júnior (SP)Moderator: Cristina Ribeiro Riguetti Pinto (RJ)Discussant: Luiz Fernando Tosi Ferreira (PR)Discussant: Murilo Quadros Berbert Freire (BA)Discussant: Paulo Ricardo Camilo de Vasconcelos (PE)
| 15:30 - 15:38 |
2026 ACC/AHA guideline: what has changed in risk stratification?
Giuliano de Almeida Sandri (ES)
|
| 15:38 - 15:46 |
DVT with pulmonary embolism: what really changes in management?
Miguel Monteiro Tannus (SP)
|
| 15:46 - 15:54 |
Mechanical thrombectomy in PE: how to improve outcomes in intermediate-high risk?
Paulo Cesar Menezes Santos (BA )
|
| 15:54 - 16:02 |
PERT team: results that transform PE management
Fábio Henrique Rossi (SP)
|
| 16:02 - 16:10 |
Related paper: Antiplatelet plus anticoagulation versus anticoagulation alone after iliofemoral venous stenting: a systematic review and meta-analysis
Gabriel Henrique Simoni (MT)
|
| 16:10 - 16:30 |
Discussion
|
16:30
SBACV GENERAL ASSEMBLY
Oct 8, 2026 (Thursday) - Elevador Lacerda Auditorium
Chair: Carlos Eduardo Pinheiro Lucio Filho (PI)Moderator: Daniel Autran Drummond (RJ)Discussant: Marcio Barreto (SP)Discussant: Túlia Brasil Simões (BA)Discussant: Ani Loize Arendt (RS)
| 08:30 - 08:38 |
How to identify the causes of venous disease recurrence on Doppler ultrasound?
Frederico Araújo Oliveira (GO)
|
| 08:38 - 08:46 |
Treating tributaries without addressing the saphenous vein: changing the order of things?
Giovani Alonghi (ITA)
|
| 08:46 - 08:54 |
Techniques for recurrent varicose veins: which is the best option?
Alexandre Reis e Silva (SP)
|
| 08:54 - 09:02 |
Thermal ablation of the anterior saphenous vein: is there a place for preemptive treatment?
Olivier Pichot (FRA)
|
| 09:02 - 09:10 |
Clinical severity of Chronic Venous Disease and obesity: what do we understand today?
Oscar Bottini (ARG)
|
| 09:10 - 09:30 |
Discussion
|
Chair: Ana Terezinha Guillaumon (SP)Moderator: Patrick Bastos Metzger (BA)Discussant: Almiro Vieira Melo (BA)Discussant: Fernanda Uchiyama (SP)Discussant: Leonardo Cortizo de Almeida (BA)
| 09:30 - 09:38 |
Iliac compression: who, when and how to intervene in the IVUS era?
Patrick Bastos Metzger (BA)
|
| 09:38 - 09:46 |
Nutcracker syndrome: real disease or overdiagnosis? When to intervene and which strategy to choose?
Ricardo Zanetti Gomes (PR)
|
| 09:46 - 09:54 |
Post-thrombotic venous occlusion: always recanalise? Techniques, limits and real-world outcomes
Walter Campos Júnior (SP)
|
| 09:54 - 10:02 |
Dedicated venous stents: revolution or marketing? Evidence, selection and how to optimise patency
Giuliano de Almeida Sandri (ES)
|
| 10:02 - 10:10 |
From anatomical design to symptom relief: the era of dedicated venous stents
Giuliano Giova Volpiani (SP)
|
| 10:10 - 10:30 |
Discussion
|
10:30 - 11:00
COFFEE BREAK
Chair: José Ben-Hur Ferraz Parente (SP)Moderator: Rodrigo Kikuchi (SP)Discussant: Gilmar da Silva Santos (BA)Discussant: Thiago Melo (BA)Discussant: Marcelo Eckert Zanoni (SC)
| 11:00 - 11:08 |
Treatment of facial veins: options and tools
Charles Esteves Pereira (GO)
|
| 11:08 - 11:16 |
Interventions on the hands and feet: what are the possibilities?
Regis Fernando Angnes (RS)
|
| 11:16 - 11:24 |
Is tumescence necessary for unsightly veins?
Arthur Curtarelli (SP)
|
| 11:24 - 11:32 |
Unsightly veins after plastic surgery: which is the best technique?
Flávia Magella (SP)
|
| 11:32 - 11:40 |
Is there a limit to treating unsightly veins: when not to indicate it?
Charles Esteves Pereira (GO)
|
| 11:40 - 12:00 |
Discussion
|
|
Opening
Julio Cesar Peclat de Oliveira
|
|
The new classification: fundamentals and clinical application
Houman Jalaie
|
|
How does the new classification change my clinical practice?
Tiago Coutas
|
|
Complex iliac vein obstruction: from classification to decision-making and clinical outcome
Geovani Fernandes
|
|
When a type 2 becomes a type 5: what changes in decision-making?
Alexandre Cesar Jahn
|
|
Extensive type 3 post-thrombotic venous occlusion: when recanalisation requires a bidirectional strategy
Tiago Bandeira
|
|
Extensive iliocaval occlusion: recanalisation from the external iliac vein to the atrium
Felipe Francescutti Murad
|
|
Questions, summary and closing
Houman Jalaie and Julio Cesar Peclat de Oliveira
|
Surgeon: Fábio Henrique Rossi (SP)Moderator: Rodrigo Gomes de Oliveira (PR)Commentator: Elias Arcenio Neto (PR)Commentator: Miguel Monteiro Tannus (SP)Commentator: Altino Ono Moraes (PR)
Chair: André Felipe Farias Braga (CE)Moderator: Tiago Rodrigues Cavalcante (MA)Discussant: André Câmara Matoso Chacon (RN)Discussant: Francine Judite Freitas Fernandes (BA)Discussant: Túlia Brasil Simões (BA)
| 13:30 - 13:38 |
Is the pelvis to blame? When gonadal and iliac reflux really explains peripheral symptoms
Fanilda Souto Barros (ES)
|
| 13:38 - 13:46 |
Who does pelvic venous embolisation work for? Evidence, controversies and patient selection
Joana Storino Pereira Costa (MG)
|
| 13:46 - 13:54 |
Pelvic venous disease: when does iliac obstruction change the therapeutic strategy?
Houman Jalaie (GER)
|
| 13:54 - 14:02 |
Management of pelvic venous disease: when to use coil embolisation?
Marcus Vinicius Martins Cury (SP)
|
| 14:02 - 14:10 |
Outcomes after embolisation: clinical success or therapeutic illusion?
Patrick Bastos Metzger (BA)
|
| 14:10 - 14:30 |
Discussion
|
Chair: Jeferson Freitas Toregeani (PR)Moderator: Bernardo Cunha Senra Barros (RJ)Discussant: Ligia Caon Pereira (RS)Discussant: Mary Gleyce de Melo Gomes Falcão (AL)Discussant: Paulo Antonaccio (SP)
| 14:30 - 14:38 |
Hybrid strategies - laser and foam: when does combining them make a difference?
Charles Esteves Pereira (GO)
|
| 14:38 - 14:46 |
LEST: are there clinical advantages over conventional laser?
Rodrigo Gomes de Oliveira (PR)
|
| 14:46 - 14:54 |
MOCA, Flebogrif and VenaSeal: where are we and where are we going?
Marcos Antonio Bonacorso Manhanelli Filho (SP)
|
| 14:54 - 15:02 |
THETA: for which patients is it the technique of choice?
Nara Medeiros Cunha de Melo Vasconcelos (RN)
|
| 15:02 - 15:10 |
Real Closure: what are the results of this innovative therapeutic option?
Fábio Henrique Rossi (SP)
|
| 15:10 - 15:18 |
Challenging case of endolaser of the saphenous veins
Paulo Antonaccio (SP)
|
| 15:18 - 15:30 |
Discussion
|
15:30 - 16:00
COFFEE BREAK
Chair: Ligia Caon Pereira (RS)Moderator: Glenda Myriam de Souza Rocha (RN)Discussant: Séfora Cerqueira de Oliveira (BA)Discussant: Juliana Puggina (SP)Discussant: Giulianna Chiacchio Vasconcelos Dias Ferraz (BA)
| 16:00 - 16:08 |
Venous disease in adolescence: agenesis, AVM or lifestyle?
Ziliane Caetano Lopes Martins (PR)
|
| 16:08 - 16:16 |
Varicose veins in pregnancy and the puerperium: when and how to intervene?
Gabriela de Oliveira Buril (PE)
|
| 16:16 - 16:24 |
Menopause and venous disease: HRT and worsening symptoms - what now?
Cris Sá (BA)
|
| 16:24 - 16:32 |
VTE prophylaxis in women: specific risk factors and practical decisions
Suzanna Maria Viana Sanches (BA)
|
| 16:32 - 16:40 |
Challenging clinical case
Nara Medeiros Cunha de Melo Vasconcelos (RN)
|
| 16:40 - 16:48 |
Related paper: Transdermal laser versus foam sclerotherapy versus combined therapy in the treatment of reticular varicose veins: preliminary results of a randomised clinical trial
Douglas Poschinger Figueiredo (RJ)
|
| 16:48 - 17:00 |
Discussion
|
Oct 9, 2026 (Friday) - Elevador Lacerda Auditorium
Chair: Regis Fernando Angnes (RS)Moderator: Elias Arcenio Neto (PR)Discussant: Thacira Dantas Almeida Ramos (PB)Discussant: Haila Almeida (MG)Discussant: Rodrigo Gomes de Oliveira (PR)
| 09:30 - 09:38 |
Doppler ultrasound of the pelvic veins: does it change management in practice?
Fanilda Souto Barros (ES)
|
| 09:38 - 09:46 |
Therapeutic planning: does staged treatment improve outcomes?
Alexandre Reis e Silva (SP)
|
| 09:46 - 09:54 |
Mapping tools for the procedure: do they change planning?
Alexandre Shiomi (PR)
|
| 09:54 - 10:02 |
Pelvic varicose veins - a new approach to endovascular treatment
Fábio Henrique Rossi (SP)
|
| 10:02 - 10:10 |
Related paper: A protocol for mapping peripheral nerves with lower limb venous Doppler: a proposal
Alexandre Yoshiharu Shiomi (PR)
|
| 10:10 - 10:30 |
Discussion
|
10:30 - 11:00
COFFEE BREAK
Chair: Sarah Sá Rodrigues Silvestre (PB)Moderator: Ana Célia Ferreira Santos (BA)Discussant: Marilia Lomonaco Galhardo (MS)Discussant: Clarisse Sales Gurgel de Azevedo (RN)Discussant: Livia Cavalcanti Braga de Lyra (MG)
| 11:00 - 11:08 |
Doppler ultrasound in CEAP C1/C2: when does it really change management?
Rodrigo Gomes de Oliveira (PR)
|
| 11:08 - 11:16 |
Telangiectasias associated with saphenous reflux and microperforators: what is the treatment sequence?
Rodrigo Bono Fukushima (SP)
|
| 11:16 - 11:24 |
Pre- and post-procedure care: real impact on aesthetic results
Renata Camila Barros Rodrigues (RO)
|
| 11:24 - 11:32 |
Combining therapeutic methods: is there an ideal plan?
José Ben-Hur Ferraz Parente (SP)
|
| 11:32 - 11:40 |
Skin complications of sclerotherapy: treating hyperpigmentation and ulceration
Juliana Lopes Camargos Sousa Leite (MG)
|
| 11:40 - 12:00 |
Discussion
|
Chair: Ana Célia Ferreira Santos (BA)Moderator: Rodrigo Kikuchi (SP)Discussant: Maria Clara Pereira Sanjuan (BA)Discussant: Jeferson Freitas Toregeani (PR)Discussant: Carlos Eduardo Pinheiro Lucio Filho (PI)
| 13:00 - 13:08 |
Liquid sclerotherapy: choosing the ideal agent
Rodrigo Gomes de Oliveira (PR)
|
| 13:08 - 13:16 |
Laser for telangiectasias: improving results by adjusting parameters
Helena Santos (RJ)
|
| 13:16 - 13:24 |
Foam sclerotherapy: is the aesthetic result satisfactory?
Solange Seguro Meyge Evangelista (MG)
|
| 13:24 - 13:32 |
Compression therapy after the procedure: impact on outcomes
Lidiane Rocha (SP)
|
| 13:32 - 13:40 |
Related paper: Randomised clinical trial on the management of tributary veins after saphenous endothermal ablation: preliminary results of a multimodal prospective protocol
Douglas Poschinger Figueiredo (RJ)
|
| 13:40 - 14:00 |
Discussion
|
Chair: Cláudio Nhuch (RS)Moderator: Rafael Rezende da Costa (RJ)Discussant: Camila Kill (SP)Discussant: Luiz Gustavo Trindade Barroso (BA)Discussant: Talita Regina Fiorio (RS)
| 14:00 - 14:08 |
Practice management: how to set achievable goals?
Dafne Braga Diamante Leiderman (SP)
|
| 14:08 - 14:16 |
Phlebology suite: investment planning stages and expected returns
Gustavo Costa Franklin dos Reis (MG)
|
| 14:16 - 14:24 |
Artificial Intelligence: how can it help your strategic planning?
Leonardo Stambowsky (RJ)
|
| 14:24 - 14:32 |
How to build a marketing strategy appropriate for the medical field?
Livia Cavalcanti Braga de Lyra (MG)
|
| 14:32 - 14:40 |
From physician to healthcare entrepreneur: does this role require a change in mindset?
Rodrigo Kikuchi (SP)
|
| 14:40 - 15:00 |
Discussion
|
15:00 - 15:30
COFFEE BREAK
Chair: Ana Célia Ferreira Santos (BA)Moderator: Daniel Autran Drummond (RJ)Discussant: Fernanda de Souza Marchezini (BA)Discussant: Lívia Ramos Carvalho Marchon (RJ)Discussant: Elias Arcenio Neto (PR)
| 15:30 - 15:38 |
The financial engineering of the practice: buy, lease or do without technology?
Rodrigo Kikuchi (SP)
|
| 15:38 - 15:46 |
AI in the venous patient journey: from image capture to the automated medical record. Where is it worth applying?
Bernardo Cunha Senra Barros (RJ)
|
| 15:46 - 15:54 |
The spectre of matting and hyperpigmentation: when aesthetics becomes a problem
Fernando Três Silveira (ES)
|
| 15:54 - 16:02 |
Treatment plans without a sales script: the ethical line between medicine and commercialisation
Livia Cavalcanti Braga de Lyra (MG)
|
| 16:02 - 16:10 |
Do you know the real cost of your procedure? Does the price charged cover overheads, risk and rework?
Dafne Braga Diamante Leiderman( SP)
|
| 16:10 - 16:30 |
The unrealistic expectation syndrome: how to identify and manage the difficult patient?
Lidiane Rocha (SP)
|
| 16:30 - 16:45 |
Discussion
|
16:45 - 17:00
CLOSING SESSION